Clinical Trial Update: Altering Lipids for Tolerance of Aromatase Inhibitor Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating on altering lipids to improve tolerance of aromatase inhibitor therapy in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED